QTREX Quantum Ltd. (QTEX): Capital Expenditures

Annual figures by period end, from SEC filings.

$103.0K
Year ended 2025-12-31
-26.8%
3-year compound annual growth
$263.0K2021-12-31: $182.0K2022-12-31: $263.0K2023-12-31: $206.0K2024-12-31: $164.0K2025-12-31: $103.0K$103.0K
2021-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$103.0K-37.2%2026-03-26, From 2025-01-01
2024-12-31$164.0K-20.4%2026-03-26, From 2024-01-01
2023-12-31$206.0K-21.7%2026-03-26, From 2023-01-01
2022-12-31$263.0K+44.5%2025-03-28, From 2022-01-01
2021-12-31$182.0Kn/a2024-03-25, From 2021-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
QTREX Quantum Ltd. (QTEX)2025-12-31$103.0K-37.2%
Pulse Biosciences, Inc. (PLSE)2025-12-31$315.0K+152.0%
Co-Diagnostics, Inc. (CODX)2025-12-31$700.0K-6.5%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2024-12-31$0-100.0%
Catheter Precision, Inc. (VTAK)2025-12-31$17.0K-74.6%
Sintx Technologies, Inc. (SINT)2025-12-31$185.0K-73.2%
RenovoRx, Inc. (RNXT)2025-12-31$2.0K-83.3%
PetVivo Holdings, Inc. (PETV)2026-03-31$7.7K-87.8%
Vivos Inc (RDGL)2025-12-31$103.2Kn/a

Compare QTEX, PLSE, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗